GLP-1 drugs like Ozempic deliver huge weight loss but new research reveals a hidden catch GLP-1 drugs like Mounjaro, Ozempic, and Wegovy offer powerful weight loss but come with big unknowns that demand independent study
The relevance to humans is unclear, but these medications are contraindicated in individuals with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2
Novo Nordisk announced that Wegovy (semaglutide) injection 0.25 mg and 0.5 mg and Ozempic are now available at a limited time price of $199 per month to new self-pay patients between now and March 31, 2026
The study used electronic health records (EHRs) from the TriNetX US Collaborative Network, covering over 100 million patients
Like the meals and want more, check out our Meal Planner Program
Regarding Semaglutide In STEP-1, semaglutide 2.4 mg showed an average weight loss of 14.9% over 68 weeks